Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076451
Company: FOUGERA PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05% CREAM;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/14/2004 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/76451ltr.pdf

FLUTICASONE PROPIONATE

CREAM;TOPICAL; 0.05%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05% CREAM;TOPICAL Prescription No AB 077055 ACP NIMBLE
FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05% CREAM;TOPICAL Prescription No AB 076633 ANDA REPOSITORY
FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05% CREAM;TOPICAL Prescription No AB 076451 FOUGERA PHARMS
FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05% CREAM;TOPICAL Prescription No AB 076793 PERRIGO ISRAEL

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English